- $481.98m
- $630.98m
- $1.32bn
- 98
- 76
- 52
- 88
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,048 | 1,016 | 1,139 | 1,231 | 1,317 |
Cost of Revenue | |||||
Gross Profit | 295 | 279 | 292 | 306 | 359 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,013 | 985 | 1,089 | 1,216 | 1,253 |
Operating Profit | 34.4 | 30.9 | 50.4 | 15.4 | 64.4 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 23.6 | 39.1 | 43.9 | 5.05 | 47.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.53 | 27.1 | 30.5 | -18.5 | 30.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 12.5 | 28.3 | 30.7 | -18.3 | 30.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 12.5 | 28.3 | 30.7 | -18.3 | 30.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.455 | 0.717 | 0.569 | 0.114 | 0.617 |
Dividends per Share |